Federal contract award

75N91023P00536

THE NCI'S SHERLOCK-LUNG STUDY IS ANALYZING CANCEROUS AND HEALTHY TISSUE FROM UP TO 2,000 NEVER-SMOKING LUNG CANCER PATIENTS AND ~500 SMOKING LUNG CANCER PATIENTS FROM THE EAGLE STUDY AND CONDUCTING MULTI-OMICS ANALYSES TO ELUCIDATE THE ETIOLOGY

Research the contractorView USAspending sourceSave to my pursuit research

Award details

Obligations, current value and potential value describe different measures; they are never added together.

FieldReported value
AgencyDepartment of Health and Human Services
OfficeNIH NCI
NAICS923110 — Administration of Education Programs
PSCB529 — Scientific Data Studies
Parent award / vehicleNot reported
Set-asideNO SET ASIDE USED.
Pricing typeFIRM FIXED PRICE
Obligations$245.0K
Current contract value$245.0K
Potential contract value / ceiling$245.0K
Start dateJun 20, 2023
Current end dateJun 19, 2026
Potential end dateJun 19, 2026
Latest award activityMay 19, 2025
Source loadedSep 26, 2026

Funding and modification history

Showing the latest 3 of 3 loaded transactions. Negative values are deobligations.

DateModificationObligation changeDescription
May 19, 2025P00002$122.5KPROVIDE ANALYTICAL SERVICES AND DEVELOP NOVEL SOFTWARE AS PART OF THE BIOINFORMATICS PIPELINE REQUIRED FOR THE GENOMIC STUDY. THE NCI'S SHERLOCK-LUNG STUDY IS ANALYZING CANCEROUS AND HEALTHY TISSUE FROM UP TO 2,000 NEVER-SMOKING LUNG CANCER PATI
Feb 1, 2024P00001$0PROVIDE ANALYTICAL SERVICES AND DEVELOP NOVEL SOFTWARE AS PART OF THE BIOINFORMATICS PIPELINE REQUIRED FOR THE GENOMIC STUDY. THE NCI'S SHERLOCK-LUNG STUDY IS ANALYZING CANCEROUS AND HEALTHY TISSUE FROM UP TO 2,000 NEVER-SMOKING LUNG CANCER PATI
Jun 15, 20230$122.5KTHE NCI'S SHERLOCK-LUNG STUDY IS ANALYZING CANCEROUS AND HEALTHY TISSUE FROM UP TO 2,000 NEVER-SMOKING LUNG CANCER PATIENTS AND ~500 SMOKING LUNG CANCER PATIENTS FROM THE EAGLE STUDY AND CONDUCTING MULTI-OMICS ANALYSES TO ELUCIDATE THE ETIOLOGY

Research next steps

  1. Check the stated set-aside against the solicitation and current certifications.
  2. Review the award scope and buyer evidence before making a bid/no-bid decision.